Abstract:ABSTRACT: The effects and mechanisms of Xinyang Maojian Extract (MJ) on obesity remain to be elucidated. To investigate the regulatory effects of MJ on high-fat diet (HFD)-induced obese mice, the chemical constituents of MJ were identified by UHPLC-Q-TOF-MS/MS, an HFD-induced obese mouse model was established, and MJ (200 and 400 mg·kg-1) was administered by gavage for 10 weeks. Biochemical assays, histopathological examination, immunofluorescence staining, 16S rRNA high-throughput sequencing, and Western blotting were performed to systematically evaluate the effects of MJ on lipid metabolism, neuroinflammation, and gut microbiota. Additionally, the expression levels of adenosine monophosphate-activated protein kinase (AMPK) and fatty acid synthase (FAS) in liver tissues were detected. It was shown that a total of 42 compounds were identified from MJ, among which 23 were flavonoids (including 9 catechins). compared with the HFD group, body weight gain in obese mice was significantly reduced by MJ-H treatment (P<0.05), glucose intolerance was ameliorated, epididymal fat was decreased by 66.67%. Hepatic lipid deposition and steatosis were alleviated, colonic mucosal injury and serum lipid metabolism disorders were ameliorated, microglial and astrocytic overactivation were inhibited, and neuroinflammation was attenuated. The Firmicutes/Bacteroidetes ratio was significantly reduced, and gut microbiota was remodeled. The p-AMPK/AMPK ratio was increased by 43.22%, and FAS expression was downregulated by 53.17%. In conclusion, HFD-induced obesity was ameliorated by MJ through multi-target regulation of the microbiota-gut-brain axis, providing a theoretical basis for the development of functional tea products from Xinyang Maojian.